Massive Volume Surge in Botanix Pharmaceuticals (ASX: BOT): Is It Finally Finding a Bottom?
Apr 20, 2026
Proactive Equities Team
Botanix Pharmaceuticals has seen a sharp volume spike after a major share price decline, hinting at possible bottoming. While Sofdra sales are growing and funding has improved liquidity, the stock remains in a downtrend, with any recovery dependent on stronger fundamentals and a break above key resistance.